Bill

Bill > HR1922


US HR1922

Restoring Access to Medication Act of 2019


summary

Introduced
03/27/2019
In Committee
10/23/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To amend the Internal Revenue Code of 1986 to include certain over-the-counter medical products as qualified medical expenses. This bill repeals provisions of the Internal Revenue Code, as added by the Patient Protection and Affordable Care Act, that limit payments for medications from health savings accounts, medical savings accounts, health flexible spending arrangements, and health reimbursement arrangements to only prescription drugs or insulin (thus allowing distributions from such accounts for over-the-counter drugs). The bill also allows the accounts to be used for menstrual care products.

AI Summary

This bill amends the Internal Revenue Code to allow the use of health savings accounts (HSAs), medical savings accounts (MSAs), health flexible spending arrangements (FSAs), and health reimbursement arrangements (HRAs) to pay for over-the-counter medical products and menstrual care products. Specifically, it repeals provisions of the Affordable Care Act that limited such accounts to only cover prescription drugs or insulin, and it allows the accounts to be used for the purchase of over-the-counter medications and menstrual care products like tampons, pads, and cups. The amendments made by this bill would apply to amounts paid or expenses incurred after December 31, 2019.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (14)

Last Action

Placed on the Union Calendar, Calendar No. 559. (on 12/18/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...